DocGo Inc. (NASDAQ:DCGO - Get Free Report) has been assigned a consensus rating of "Hold" from the five analysts that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $2.25.
DCGO has been the subject of a number of research reports. Weiss Ratings reiterated a "sell (d-)" rating on shares of DocGo in a report on Monday, December 29th. Canaccord Genuity Group reduced their price objective on DocGo from $1.60 to $1.50 and set a "buy" rating on the stock in a report on Wednesday, November 12th.
View Our Latest Stock Analysis on DCGO
Hedge Funds Weigh In On DocGo
Institutional investors have recently made changes to their positions in the company. Neuberger Berman Group LLC bought a new stake in shares of DocGo in the fourth quarter valued at about $29,000. Cerity Partners LLC bought a new position in DocGo during the 2nd quarter worth about $37,000. Public Employees Retirement System of Ohio purchased a new position in DocGo during the 4th quarter valued at about $40,000. Engineers Gate Manager LP purchased a new position in DocGo during the 2nd quarter valued at about $52,000. Finally, Royce & Associates LP bought a new stake in shares of DocGo in the 3rd quarter valued at about $64,000. Hedge funds and other institutional investors own 56.44% of the company's stock.
DocGo Price Performance
Shares of DCGO stock opened at $0.67 on Tuesday. The company has a market capitalization of $65.75 million, a P/E ratio of -1.29 and a beta of 0.95. The company's 50-day simple moving average is $0.80 and its two-hundred day simple moving average is $1.06. DocGo has a one year low of $0.63 and a one year high of $3.08.
DocGo Company Profile
(
Get Free Report)
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.